Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin

Código QR

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin

Stanley S SchwartzDiabetes Disease Management at the University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia Heart Institute, Philadelphia, Pennsylvania, USAAbstract: Insulin resistance and impaired beta-cell function are primary defects that occur early in the course of developme...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Schwartz S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Thiazolidinediones Pioglitazone insulin resistance type 2 diabetes insulin Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/33e4a4e1bbd24cc692ca6be2cb52a8c4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
por: Wondmkun YT
Publicado: (2020)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Stanley S Schwartz
Publicado: (2010)

Diabetes autoinmune (latente) del adulto
por: Pollak C,Felipe, et al.
Publicado: (2012)

The Association Between Insulin Resistance, Leptin, and Resistin and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients with Different Body Mass Indexes
por: Huang J, et al.
Publicado: (2021)

Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
por: Cai X, et al.
Publicado: (2020)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau IT, et al.
Publicado: (2017)

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
por: Zhang F, et al.
Publicado: (2021)

Chaperone-Based Therapeutic Target Innovation: Heat Shock Protein 70 (HSP70) for Type 2 Diabetes Mellitus
por: Mulyani WRW, et al.
Publicado: (2020)

The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans
por: Juan P. Palavicini, et al.
Publicado: (2021)

Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Liu D, et al.
Publicado: (2021)

The Role of JNk Signaling Pathway in Obesity-Driven Insulin Resistance
por: Feng J, et al.
Publicado: (2020)

Comparative Effects of Curcumin versus Nano-Curcumin on Insulin Resistance, Serum Levels of Apelin and Lipid Profile in Type 2 Diabetic Rats
por: Shamsi-Goushki A, et al.
Publicado: (2020)

Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study
por: Ji L, et al.
Publicado: (2016)

Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
por: Pollock RF, et al.
Publicado: (2018)

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
por: Kress S, et al.
Publicado: (2021)

Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
por: Kalirai S, et al.
Publicado: (2020)

Statin on insulin and adiponectin levels: true or false prophecy?
por: Jonnalagadda VG, et al.
Publicado: (2018)

Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients
por: Zhou X, et al.
Publicado: (2021)

Correlation Between Serum Uric Acid Level and Central Body Fat Distribution in Patients with Type 2 Diabetes
por: Zong J, et al.
Publicado: (2020)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
por: Le Floch J
Publicado: (2010)

A Comparison Between the Therapeutic Effect of Metformin Alone versus a Combination Therapy with Insulin in Uncontrolled, Non-Adherence Patients with Type 2 Diabetes: Six Months Follow-Up
por: Paczkowska A, et al.
Publicado: (2021)

Efficacy and Safety of a Decision Support Intervention for Basal Insulin Self-Titration Assisted by the Nurse in Outpatients with T2DM: A Randomized Controlled Trial
por: Hu X, et al.
Publicado: (2021)

Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats
por: Mi J, et al.
Publicado: (2019)

“Adjusting Internal Organs and Dredging Channel” Electroacupuncture Ameliorates Insulin Resistance in Type 2 Diabetes Mellitus by Regulating the Intestinal Flora and Inhibiting Inflammation
por: Zhang L, et al.
Publicado: (2021)

Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
por: Pingali U, et al.
Publicado: (2020)

Practical combination therapy based on pathophysiology of type 2 diabetes
por: Levin PA
Publicado: (2016)

An Integrated Approach Based on Network Pharmacology Combined with Experimental Verification Reveals AMPK/PI3K/Akt Signaling is an Important Way for the Anti-Type 2 Diabetic Activity of Silkworm Excrement
por: Duan H, et al.
Publicado: (2021)

Long‐term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome
por: Albai O, et al.
Publicado: (2020)

Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges
por: Vilarrasa N, et al.
Publicado: (2021)

Osteoclasts May Affect Glucose Uptake-Related Insulin Resistance by Secreting Resistin
por: Li X, et al.
Publicado: (2021)

The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
por: Shafie Pour MR, et al.
Publicado: (2019)

Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
por: He X, et al.
Publicado: (2020)

Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus
por: Le TD, et al.
Publicado: (2020)

Relationship Between the TyG Index and Diabetic Kidney Disease in Patients with Type-2 Diabetes Mellitus
por: Lv L, et al.
Publicado: (2021)

Beta-cell function is associated with metabolic syndrome in Mexican subjects
por: PÃ©rez-Fuentes
Publicado: (2010)

Metabolic Score for Insulin Resistance Is Correlated to Adipokine Disorder and Inflammatory Activity in Female Knee Osteoarthritis Patients in a Chinese Population
por: Ding L, et al.
Publicado: (2020)

Identification of Significant Predictors for the Need of Insulin Therapy and Onset of Postpartum Impaired Glucose Tolerance in Gestational Diabetes Mellitus Patients
por: Wang T, et al.
Publicado: (2021)

Effect of Insulin-Regulated FOXC2 Expression in Adipocyte Differentiation and Insulin Resistance
por: Zhang X, et al.
Publicado: (2020)

Relationship Between Vitamin D Status and the Relevant Parameters of Glucose in Patients with Type 2 Diabetes
por: Tran Huu TT, et al.
Publicado: (2021)

Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
por: Thomann R, et al.
Publicado: (2020)